Source: BioPortfolio

Prexton Therapeutics: Prexton Therapeutics SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17102017 Prices from USD $250

SummaryPrexton Therapeutics SA Prexton is a drug development company that develops drugs for Parkinson's disease and other brain disorders. The company specializes in the designing of mGluR4 PAM compounds for the treatment for Parkinson's disease. It also ...

Read full article »
Prexton Therapeutics's Competitors | Prexton Therapeutics's News | Prexton Therapeutics's Financials
Stay up-to-date with the latest news on Prexton Therapeutics
Est. Annual Revenue
$100K-5.0M
Est. Employees
250-500
François Conquet's photo - Founder & CEO of Prexton Therapeutics

Founder & CEO

François Conquet

CEO Approval Rating

75/100

Read more
Stay up-to-date with the latest news on Prexton Therapeutics